Given the role of p53 as a redox-sensitive transcription factor in ROS regulation [23], we analyzed Txnrd1 mRNA expression in GBM tumor tissues based on their wild-type or mutant (mut) TP53 status. This evidence concerns the gene TP53 and glioblastoma.